ADAGIO: a phase IIb international study of the Wee1 inhibitor adavosertib in women with recurrent or persistent uterine serous carcinoma
Joyce F. Liu, Amit M. Oza, Nicoletta Colombo, Ana Oaknin
Topics & Concepts
MedicineSerous carcinomaSerous fluidClinical endpointResponse Evaluation Criteria in Solid TumorsOncologyInternal medicineCarcinomaCarcinosarcomaGynecologyPhases of clinical researchClinical trialCancerOvarian cancerEndometrial and Cervical Cancer TreatmentsCell death mechanisms and regulation14-3-3 protein interactions